• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

量化类风湿关节炎导致的生产力损失的经济负担。

Quantifying the economic burden of productivity loss in rheumatoid arthritis.

机构信息

Health Economics and Outcomes Research Department, Abbott Laboratories Limited, Maidenhead, UK.

出版信息

Rheumatology (Oxford). 2011 Jun;50(6):1083-90. doi: 10.1093/rheumatology/keq399. Epub 2011 Jan 18.

DOI:10.1093/rheumatology/keq399
PMID:21245074
Abstract

OBJECTIVE

In light of the large number of recent studies and systematic reviews investigating the cost of RA, this article examines the methods used to assess the impact of RA on employment and work productivity, and provides an overview of the issues surrounding work productivity loss in the RA population.

METHODS

A review of the published literature was conducted in order to identify relevant articles. These articles were then reviewed and their methodologies compared. The various methods used to calculate economic loss were then explained and discussed.

RESULTS

We found that although methods of lost productivity and associated costs varied between studies, all suggest that RA is associated with significant burden of illness. Economic analyses that exclude indirect costs will therefore underestimate the full economic impact of RA. However, the methods used to calculate productivity loss have a significant impact on the results of indirect cost analyses, and should be selected carefully when designing such studies. Several factors relating to the disease, the job and socio-demographics have been found to predict work disability.

CONCLUSIONS

Consideration of these factors is vital when measuring the extent of both absenteeism and presenteeism, and will allow for more accurate estimation of the impact of RA on work productivity. This information may also guide interventions aiming to prevent or postpone work disability and job loss.

摘要

目的

鉴于最近有大量研究和系统评价探讨类风湿关节炎(RA)的成本,本文检查了评估 RA 对就业和工作生产力影响的方法,并概述了 RA 人群中工作生产力损失的相关问题。

方法

进行了已发表文献的综述,以确定相关文章。然后对这些文章进行了回顾,并比较了它们的方法。然后解释和讨论了计算经济损失的各种方法。

结果

我们发现,尽管生产力损失的方法和相关成本在研究之间存在差异,但都表明 RA 与重大疾病负担相关。因此,排除间接成本的经济分析将低估 RA 的全部经济影响。然而,用于计算生产力损失的方法对间接成本分析的结果有重大影响,在设计此类研究时应谨慎选择。已发现与疾病、工作和社会人口统计学相关的几个因素可预测工作残疾。

结论

在衡量旷工和在职缺勤的程度时,考虑这些因素至关重要,这将更准确地估计 RA 对工作生产力的影响。这些信息还可以指导旨在预防或推迟工作残疾和失业的干预措施。

相似文献

1
Quantifying the economic burden of productivity loss in rheumatoid arthritis.量化类风湿关节炎导致的生产力损失的经济负担。
Rheumatology (Oxford). 2011 Jun;50(6):1083-90. doi: 10.1093/rheumatology/keq399. Epub 2011 Jan 18.
2
Critical analysis of economic tools and economic measurement applied to rheumatoid arthritis.类风湿关节炎中经济工具和经济衡量的批判性分析。
Clin Exp Rheumatol. 2012 Jul-Aug;30(4 Suppl 73):S107-11. Epub 2012 Oct 16.
3
Indirect Costs of Rheumatoid Arthritis Depending on Type of Treatment-A Systematic Literature Review.类风湿关节炎的间接成本取决于治疗类型——系统文献回顾。
Int J Environ Res Public Health. 2019 Aug 17;16(16):2966. doi: 10.3390/ijerph16162966.
4
Impact of etanercept on work and activity impairment in employed moderate to severe rheumatoid arthritis patients in the United States.在美国,依那西普对中重度类风湿关节炎患者的工作和活动障碍的影响。
Arthritis Care Res (Hoboken). 2013 Oct;65(10):1564-72. doi: 10.1002/acr.22022.
5
Burden of rheumatoid arthritis from a societal perspective: A prevalence-based study on cost of this illness for patients in China.从社会角度看类风湿关节炎的负担:一项基于患病率的中国患者本病成本研究。
Int J Rheum Dis. 2018 Aug;21(8):1572-1580. doi: 10.1111/1756-185X.13028. Epub 2017 Feb 17.
6
Employer model of workplace impacts of anti-TNF therapy for rheumatoid arthritis.雇主模式下抗 TNF 治疗类风湿关节炎的职场影响。
J Occup Environ Med. 2009 Oct;51(10):1167-76. doi: 10.1097/JOM.0b013e3181b8c397.
7
Economic impact of adalimumab treatment in Japanese patients with rheumatoid arthritis from the adalimumab non-interventional trial for up-verified effects and utility (ANOUVEAU) study.阿达木单抗用于类风湿关节炎日本患者治疗的经济影响:来自阿达木单抗疗效及实用性验证非干预性试验(ANOUVEAU)研究
Mod Rheumatol. 2018 Jan;28(1):39-47. doi: 10.1080/14397595.2017.1341459. Epub 2017 Jul 13.
8
Indirect costs assessment and intangible costs description of rheumatoid arthritis patients with biological therapy in Morocco: ECORAM Study.摩洛哥生物治疗类风湿关节炎患者的间接成本评估和无形成本描述:ECORAM 研究。
Int J Rheum Dis. 2024 Oct;27(10):e15367. doi: 10.1111/1756-185X.15367.
9
Rheumatoid arthritis and work: The impact of rheumatoid arthritis on absenteeism and presenteeism.类风湿性关节炎与工作:类风湿性关节炎对旷工和出勤的影响。
Best Pract Res Clin Rheumatol. 2015 Jun;29(3):495-511. doi: 10.1016/j.berh.2015.06.001. Epub 2015 Jul 14.
10
Productivity cost model of the treatment of rheumatoid arthritis with abatacept.阿巴西普治疗类风湿关节炎的生产力成本模型。
J Med Econ. 2008;11(1):3-21. doi: 10.3111/13696990701748837.

引用本文的文献

1
Excess costs of depression among a population-based older adults with chronic diseases in Singapore.新加坡基于人群的慢性病老年患者中抑郁的额外成本。
BMC Public Health. 2024 Nov 11;24(1):3119. doi: 10.1186/s12889-024-20306-1.
2
Employment of patients with rheumatoid arthritis - a systematic review and meta-analysis.类风湿关节炎患者的就业情况——一项系统评价与荟萃分析
BMC Rheumatol. 2023 Nov 14;7(1):41. doi: 10.1186/s41927-023-00365-4.
3
Physical Exercise and Occupational Therapy at Home to Improve the Quality of Life in Subjects Affected by Rheumatoid Arthritis: A Randomized Controlled Trial.
在家进行体育锻炼和职业治疗以改善类风湿关节炎患者的生活质量:一项随机对照试验
Healthcare (Basel). 2023 Jul 25;11(15):2123. doi: 10.3390/healthcare11152123.
4
Systematic Literature Review of the Use of Productivity Losses/Gains in Cost-Effectiveness Analyses of Immune-Mediated Disorders.免疫介导性疾病成本效益分析中使用生产力损失/增益的系统文献回顾。
Adv Ther. 2022 Dec;39(12):5327-5350. doi: 10.1007/s12325-022-02321-z. Epub 2022 Oct 7.
5
Treatment pattern, satisfaction, and productivity loss of patients with ankylosing spondylitis treated with tumor necrosis factor inhibitors in Korea: A multicenter cross-sectional observational study.韩国接受肿瘤坏死因子抑制剂治疗的强直性脊柱炎患者的治疗模式、满意度和生产力损失:一项多中心横断面观察性研究。
Int J Rheum Dis. 2022 May;25(5):523-531. doi: 10.1111/1756-185X.14304. Epub 2022 Feb 20.
6
A health economics study of long-acting injectable once-monthly paliperidone palmitate in schizophrenia: a one-year mirror-image study in China.长效注射用帕利哌酮棕榈酸酯治疗精神分裂症的卫生经济学研究:中国为期一年的镜像研究。
BMC Psychiatry. 2022 Feb 8;22(1):95. doi: 10.1186/s12888-022-03728-2.
7
Cost-of-Illness Progression Before and After Diagnosis of Multiple Sclerosis: A Nationwide Register-Based Cohort Study in Sweden of People Newly Diagnosed with Multiple Sclerosis and a Population-Based Matched Reference Group.多发性硬化症诊断前后疾病经济负担的演变:瑞典一项基于全国登记的多发性硬化症新诊断患者队列研究及其基于人群的匹配参照组
Pharmacoeconomics. 2021 Jul;39(7):835-851. doi: 10.1007/s40273-021-01035-4. Epub 2021 May 10.
8
Distinct Single Cell Gene Expression in Peripheral Blood Monocytes Correlates With Tumor Necrosis Factor Inhibitor Treatment Response Groups Defined by Type I Interferon in Rheumatoid Arthritis.外周血单核细胞中独特的单细胞基因表达与类风湿关节炎中 I 型干扰素定义的肿瘤坏死因子抑制剂治疗反应组相关。
Front Immunol. 2020 Jul 16;11:1384. doi: 10.3389/fimmu.2020.01384. eCollection 2020.
9
The cost-effectiveness of using pneumococcal conjugate vaccine (PCV13) versus pneumococcal polysaccharide vaccine (PPSV23), in South African adults.南非成年人中使用肺炎球菌结合疫苗(PCV13)与肺炎球菌多糖疫苗(PPSV23)的成本效益比较。
PLoS One. 2020 Jan 29;15(1):e0227945. doi: 10.1371/journal.pone.0227945. eCollection 2020.
10
Perceptions of first-degree relatives of patients with rheumatoid arthritis about lifestyle modifications and pharmacological interventions to reduce the risk of rheumatoid arthritis development: a qualitative interview study.类风湿关节炎患者一级亲属对通过生活方式改变和药物干预降低类风湿关节炎发病风险的看法:一项定性访谈研究
BMC Rheumatol. 2018 Nov 6;2:31. doi: 10.1186/s41927-018-0038-3. eCollection 2018.